Talkspace (TALK) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $0.01
- Estimate
- $0.03
- Surprise
- -71.4%
- Revenue (period 2026-06-30)
- $61.7M
- Score today
- 5.4/10
Revenue source: xbrl.
How the report landed
Talkspace (TALK) missed the $0.03 estimate with diluted EPS of $0.01 — a large 71.4% shortfall.
Where TrendMatrix's rating stands now
TrendMatrix currently rates TALK Sell at 5.4/10; no pre/post engine snapshot brackets this report.
0 of the last 4 quarters beat the estimate; this quarter's -71.4% surprise compares with a -20.5% four-quarter average. Next scheduled report: 2026-10-29.
What supports the rating
- Positive momentum
What argues against it
- Thin upside margin: 3.2%
- Near 52-week high (0.0% away)
- Value-trap signals (2/5): Margin compression (op margin -2.0%), Material insider selling (5 sells, 0.06% of cap)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $5.24
- Price target
- $5.42
- Stop
- $5.19
- Upside to target
- +3.4%
- Reward-to-risk
- 0.2:1
Model outputs from TrendMatrix’s engine as of 2026-08-23 — shown for context, not personalized investment advice.
TALK at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Health Information Services
- Market cap
- $870.6M
- P/E (fwd)
- 29.2
- 52-week range
- $2.49–$5.25
- Off 52-week high
- 0.2%
- RSI (14)
- 57
- Volume vs avg
- 1.47×
- Score today
- 5.4/10